Cited by 138Attention Deficit Hyperactivity DisorderPharmacology and Obesity TreatmentNeuroethics, Human Enhancement, Biomedical Innovations

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis

Open access
Mészáros, Ágnes, Czobor, Pál, Bálint, Sára, Komlósi, Sarolta, Simon, Viktória, Bitter, István·2009·The International Journal of Neuropsychopharmacology

Abstract

Our objective was to conduct a meta-analysis of therapeutic efficacy of pharmacological treatment of adult ADHD based on data from controlled clinical trials. We used the search engines PubMed and Medline to identify relevant clinical trials. Short-term studies with double-blind parallel-group design were selected for the analysis. Altogether, we identified 11 trials that met the criteria, and investigated a total of 1991 subjects, 694 and 1297 of whom were treated with placebo or active medication, respectively. In order to pool efficacy data from studies with different characteristics, including different number of participants, different trial duration and measures of efficacy, the statistical effect sizes for each study had to be calculated. Our findings showed that the pooled effect size across all treatments was in the medium-to-high range (Cohen's d=0.65, p<0.0001 vs. placebo), and the effect size for stimulants (Cohen's d=0.67, p<0.0001 vs. placebo) was somewhat higher than for non-stimulant medications (Cohen's d=0.59, p<0.0001 vs. placebo). The current database of controlled trials for adult ADHD is relatively small, and does not include data for many of the potentially important agents. In addition, effect-size estimates for different classes of medications (i.e. stimulant and non-stimulant medications) were based on separate studies; head-to-head comparisons of various agents are severely lacking. Nonetheless, results of this meta-analysis across all ADHD medications in adult subjects demonstrated statistically significant and clinically robust improvement in symptom severity compared to placebo treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145709990198

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Conners CK (1998). Rating scales in attention-deficit/ hyperactivity disorder : use in assessment and treatment monitoring. Journal of Clinical Psychiatry 59, 24-30.
  2. National Institute of Mental Health (NIMH) (1985). CGI (Clinical Global Impression Scale). Psychopharmacological Bulletin 4, 839-844.
  3. Ward MF, Wender PH, Reimherr FW (1993). The Wender Utah Rating-Scale -an aid in the retrospective diagnosis of childhood attention-deficit hyperactivity disorder. American Journal of Psychiatry 150, 885-890.
  4. Wilens TE, Biederman J, Prince J, Spencer TJ, et al. (1996). Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry 153, 1147-1153.
  5. Wilens TE, Spencer TJ, Biederman J, Girard K, et al. (2001). A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry 158, 282-288.

Cited by

Sorted by citations

Authors
Mészáros, Á., Czobor, P., Bálint, S., Komlósi, S., Simon, V., & Bitter, I.
Affiliations
Semmelweis University (HU)
Corresponding author
Mészáros, Ágnes
Venue
The International Journal of Neuropsychopharmacology
Published
2009-07-07
Volume
12
Issue
08
Pages
1137
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2001828543
Cited by
138
References
62
Citations by year
2026: 3 · 2025: 7 · 2024: 7 · 2023: 2 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 4 · 2018: 6 · 2017: 10 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 9 · 2012: 14
FWCI
1.47
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
Keywords
adult ADHD, pharmacotherapy, stimulant medication, non-stimulant medication, placebo comparison, symptom severity, treatment efficacy, effect size
MeSH terms
Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Clinical Trials as Topic, Combined Modality Therapy, Female, Humans, Male, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review